NB006209
Cytomegalovirus p65 Antibody (CMV100), FITC, Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB006209-Each-of-1 | In Stock | ₹ 53,688.90 |
NB006209 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 53,688.90
GST (18%): ₹ 9,664.002
Total Price: ₹ 63,352.902
Antigen
Cytomegalovirus p65
Classification
Monoclonal
Conjugate
FITC
Formulation
PBS with 0.05% Sodium Azide
Host Species
Mouse
Purification Method
Protein A or G purified
Regulatory Status
RUO
Primary or Secondary
Primary
Target Species
Cytomegalovirus (CMV), Virus
Isotype
IgG1 κ
Applications
ELISA, Immunocytochemistry, Immunofluorescence
Clone
CMV100
Dilution
ELISA, Immunocytochemistry/Immunofluorescence
Gene Alias
CMV, p65
Immunogen
Recombinant CMV-p65 protein
Quantity
0.1 mL
Research Discipline
Immunology, Infections (Virus Bacteria and Parasites), Virology Bacteria and Parasites
Test Specificity
Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.
Content And Storage
Store at 4°C in the dark.
Related Products
Description
- Cytomegalovirus p65 Monoclonal specifically detects Cytomegalovirus p65 in Cytomegalovirus, Virus samples
- It is validated for ELISA.
Compare Similar Items
Show Difference
Antigen: Cytomegalovirus p65
Classification: Monoclonal
Conjugate: FITC
Formulation: PBS with 0.05% Sodium Azide
Host Species: Mouse
Purification Method: Protein A or G purified
Regulatory Status: RUO
Primary or Secondary: Primary
Target Species: Cytomegalovirus (CMV), Virus
Isotype: IgG1 κ
Applications: ELISA, Immunocytochemistry, Immunofluorescence
Clone: CMV100
Dilution: ELISA, Immunocytochemistry/Immunofluorescence
Gene Alias: CMV, p65
Immunogen: Recombinant CMV-p65 protein
Quantity: 0.1 mL
Research Discipline: Immunology, Infections (Virus Bacteria and Parasites), Virology Bacteria and Parasites
Test Specificity: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.
Content And Storage: Store at 4°C in the dark.
Antigen:
Cytomegalovirus p65
Classification:
Monoclonal
Conjugate:
FITC
Formulation:
PBS with 0.05% Sodium Azide
Host Species:
Mouse
Purification Method:
Protein A or G purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Target Species:
Cytomegalovirus (CMV), Virus
Isotype:
IgG1 κ
Applications:
ELISA, Immunocytochemistry, Immunofluorescence
Clone:
CMV100
Dilution:
ELISA, Immunocytochemistry/Immunofluorescence
Gene Alias:
CMV, p65
Immunogen:
Recombinant CMV-p65 protein
Quantity:
0.1 mL
Research Discipline:
Immunology, Infections (Virus Bacteria and Parasites), Virology Bacteria and Parasites
Test Specificity:
Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.
Content And Storage:
Store at 4°C in the dark.
Antigen: Cytomegalovirus p65
Classification: Monoclonal
Conjugate: Alexa Fluor 350
Formulation: 50mM Sodium Borate with 0.05% Sodium Azide
Host Species: Mouse
Purification Method: Protein A or G purified
Regulatory Status: RUO
Primary or Secondary: Primary
Target Species: Cytomegalovirus (CMV), Virus
Isotype: IgG1 κ
Applications: ELISA, Immunocytochemistry, Immunofluorescence
Clone: CMV101
Dilution: ELISA, Immunocytochemistry/Immunofluorescence
Gene Alias: CMV, p65
Immunogen: Recombinant CMV-p65 protein
Quantity: 0.1 mL
Research Discipline: Immunology, Infections (Virus Bacteria and Parasites), Virology Bacteria and Parasites
Test Specificity: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.
Content And Storage: Store at 4°C in the dark.
Antigen:
Cytomegalovirus p65
Classification:
Monoclonal
Conjugate:
Alexa Fluor 350
Formulation:
50mM Sodium Borate with 0.05% Sodium Azide
Host Species:
Mouse
Purification Method:
Protein A or G purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Target Species:
Cytomegalovirus (CMV), Virus
Isotype:
IgG1 κ
Applications:
ELISA, Immunocytochemistry, Immunofluorescence
Clone:
CMV101
Dilution:
ELISA, Immunocytochemistry/Immunofluorescence
Gene Alias:
CMV, p65
Immunogen:
Recombinant CMV-p65 protein
Quantity:
0.1 mL
Research Discipline:
Immunology, Infections (Virus Bacteria and Parasites), Virology Bacteria and Parasites
Test Specificity:
Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.
Content And Storage:
Store at 4°C in the dark.
Antigen: Cytomegalovirus p65
Classification: Monoclonal
Conjugate: Alexa Fluor 594
Formulation: 50mM Sodium Borate with 0.05% Sodium Azide
Host Species: Mouse
Purification Method: Protein A or G purified
Regulatory Status: RUO
Primary or Secondary: Primary
Target Species: Cytomegalovirus (CMV), Virus
Isotype: IgG1 κ
Applications: ELISA, Immunocytochemistry, Immunofluorescence
Clone: CMV101
Dilution: ELISA, Immunocytochemistry/Immunofluorescence
Gene Alias: CMV, p65
Immunogen: Recombinant CMV-p65 protein
Quantity: 0.1 mL
Research Discipline: Immunology, Infections (Virus Bacteria and Parasites), Virology Bacteria and Parasites
Test Specificity: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.
Content And Storage: Store at 4°C in the dark.
Antigen:
Cytomegalovirus p65
Classification:
Monoclonal
Conjugate:
Alexa Fluor 594
Formulation:
50mM Sodium Borate with 0.05% Sodium Azide
Host Species:
Mouse
Purification Method:
Protein A or G purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Target Species:
Cytomegalovirus (CMV), Virus
Isotype:
IgG1 κ
Applications:
ELISA, Immunocytochemistry, Immunofluorescence
Clone:
CMV101
Dilution:
ELISA, Immunocytochemistry/Immunofluorescence
Gene Alias:
CMV, p65
Immunogen:
Recombinant CMV-p65 protein
Quantity:
0.1 mL
Research Discipline:
Immunology, Infections (Virus Bacteria and Parasites), Virology Bacteria and Parasites
Test Specificity:
Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.
Content And Storage:
Store at 4°C in the dark.
Antigen: Cytomegalovirus p65
Classification: Monoclonal
Conjugate: FITC
Formulation: PBS with 0.05% Sodium Azide
Host Species: Mouse
Purification Method: Protein A or G purified
Regulatory Status: RUO
Primary or Secondary: Primary
Target Species: Cytomegalovirus (CMV), Virus
Isotype: IgG1 κ
Applications: ELISA, Immunocytochemistry, Immunofluorescence
Clone: CMV101
Dilution: ELISA, Immunocytochemistry/Immunofluorescence
Gene Alias: CMV, p65
Immunogen: Recombinant CMV-p65 protein
Quantity: 0.1 mL
Research Discipline: Immunology, Infections (Virus Bacteria and Parasites), Virology Bacteria and Parasites
Test Specificity: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.
Content And Storage: Store at 4°C in the dark.
Antigen:
Cytomegalovirus p65
Classification:
Monoclonal
Conjugate:
FITC
Formulation:
PBS with 0.05% Sodium Azide
Host Species:
Mouse
Purification Method:
Protein A or G purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Target Species:
Cytomegalovirus (CMV), Virus
Isotype:
IgG1 κ
Applications:
ELISA, Immunocytochemistry, Immunofluorescence
Clone:
CMV101
Dilution:
ELISA, Immunocytochemistry/Immunofluorescence
Gene Alias:
CMV, p65
Immunogen:
Recombinant CMV-p65 protein
Quantity:
0.1 mL
Research Discipline:
Immunology, Infections (Virus Bacteria and Parasites), Virology Bacteria and Parasites
Test Specificity:
Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.
Content And Storage:
Store at 4°C in the dark.